tumors from neural stem cells also contained more glioblastoma stem cells, cells that are believed to give rise to tumor
recurrence after therapy,» says Lene Uhrbom, senior lecturer at the Department of Immunology, Genetics and Pathology and lead author of the study.
Not exact matches
«In order to block tumor
recurrence after radiation
therapy, we used an antibody to target and inhibit these cancer stem cells,» said Dr. Xu.
As reported in 2015, the study met its primary endpoint
after a median follow up of 2.3 years, with ipilimumab significantly improving
recurrence - free survival.2 The drug was subsequently approved by the US Food and Drug Administration as adjuvant
therapy for stage III melanoma.
«Initial data from TAILORx breast cancer trial published: TAILORx trial finds 99 percent of women with low Oncotype DX ®
Recurrence Score ® are free of breast cancer recurrence after 5 years of hormone therapy alo
Recurrence Score ® are free of breast cancer
recurrence after 5 years of hormone therapy alo
recurrence after 5 years of hormone
therapy alone.»
«We have identified a subgroup of older patients at sufficiently low risk of
recurrence for whom omission of postoperative radiotherapy
after breast - conserving surgery and adjuvant endocrine
therapy is a reasonable option.
Toxicity and disease
recurrence assessment was conducted weekly while patients received radiation
therapy; four months
after treatment completion; every three months for one - and - a-half years; every four months between one - and - a-half and three years; every six months in years three to five; and then annually until death.
Also, the research showed that this localised delivery of combination
therapy significantly inhibited the
recurrence of cancer
after a primary tumour was surgically removed.
In melanoma patients who are also treated with the immune
therapy pembrolizumab
after surgery, the risk of
recurrence of the disease is almost twice as small as in patients who receive a placebo.
Two winters
after the treatments, 46 percent of those who had received light
therapy had a
recurrence of depression, compared to just 27 percent of the cognitive -
therapy subjects.
Systemic
therapies are often given
after surgery for those with a greater risk for cancer
recurrence.
Radiation
Therapy Prolongs Life in Men with Recurrent Prostate Cancer Men whose tumors recur
after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the
recurrence.
Positron emission tomography (PET) imaging of metabolic tumor burden at diagnosis and
after induction
therapy can help identify patients most at risk of follicular lymphoma (FL)
recurrence, but more work is needed to differentiate high - risk and moderate - risk patients, suggested findings from a pooled analysis of data from three prospective clinical trials, published in Blood.
Both of these novel
therapies have, however, shown varying clinical results with disappointing cancer
recurrences after initially promising responses (13, 46).
TAILORx trial finds 99 percent of women with low Oncotype DX ®
Recurrence Score ® are free of breast cancer recurrence after five years of hormone ther
Recurrence Score ® are free of breast cancer
recurrence after five years of hormone ther
recurrence after five years of hormone
therapy alone.
Slow down lymphoma growth modestly and show no effect on tumor regression; delay tumor
recurrence with activation of p53; enhance tumor regression and inhibit tumor
recurrence after alkylating drug
therapy.
These results, also presented at the 2015 European Cancer Congress (ECC2015, abstract # 5BA) today, which involve the group of 1,626 patients with a
Recurrence Score between 0 and 10, demonstrated that 99.3 percent of node - negative, estrogen receptor (ER)- positive, human epidermal growth factor receptor 2 (HER2)- negative patients who met accepted guidelines for recommending chemotherapy in addition to hormonal therapy, had no distant recurrence at five years after treatment with hormonal ther
Recurrence Score between 0 and 10, demonstrated that 99.3 percent of node - negative, estrogen receptor (ER)- positive, human epidermal growth factor receptor 2 (HER2)- negative patients who met accepted guidelines for recommending chemotherapy in addition to hormonal
therapy, had no distant
recurrence at five years after treatment with hormonal ther
recurrence at five years
after treatment with hormonal
therapy alone.
Among these studies are studies on more than 19,000 children representing of 47,000 patient years of growth hormone treatment; a prospective study of 100 adult growth hormone — deficient patients followed for 1 to 4 years, a study of 910 children treated with growth hormone for 11 years, a study of 32 adults and children followed for up to 40 years treated with growth hormone (average 10.8 years); a study of 180 growth hormone — treated children followed for over 6 years with reduced cancer
recurrence risk (RR 0.6); a prospective analysis of 289 growth hormone — deficient adults who,
after 5 years of growth hormone
therapy, showed lower risk of malignancy (RR 0.25) and decreased risk of myocardial infarction (RR 0.19) and early mortality (RR 0.22) compared with the untreated group.
Recurrence of hyperthyroidism is rare
after I - 131
therapy.
Continuation - phase cognitive
therapy and fluoxetine are effective in reducing the risk of relapse /
recurrence in major depression
after incomplete remission
The CBT and Family
Therapy conditions had a lower rate of
recurrence of abuse (5 % and 6 %) than RCS (30 % one year
after the completion of treatment, but the difference was not statistically significant.